Capital expenditure increased 289.0%
Capital expenditure changed +289.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +289.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +339 basis points from the comparable as-filed period.
Operating cash-flow margin changed +354 basis points from the comparable as-filed period.
Receivables / revenue changed -400 basis points from the comparable as-filed period.
Current liabilities changed +14.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +251 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +15 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -37 basis points from the comparable as-filed period.
Stock-based compensation changed +16.2% from the comparable as-filed period.
Free-cash-flow margin changed +363 basis points from the comparable as-filed period.
Operating cash-flow margin changed +364 basis points from the comparable as-filed period.
Capital expenditure changed +71.8% from the comparable as-filed period.
Trade receivables changed +22.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed +13.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital / assets changed +247 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed +15 basis points from the comparable as-filed period.
Capex / revenue changed +1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +20.0% from the comparable as-filed period.
SBC / revenue changed -41 basis points from the comparable as-filed period.
Receivables / revenue changed -128 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.